跳至主要内容
临床试验/EUCTR2017-003164-13-NL
EUCTR2017-003164-13-NL进行中(未招募)1 期

Antibiotic prophylaxis for children with recurrent respiratory infections: towards evidence-based guidelines - AppROaCH study

Haga Teaching Hospital (Juliana Children's Hospital)0 个研究点目标入组 158 人开始时间: 2018年5月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
158

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • - Presenting to one of the participating clinics;
  • - Age 6 months – 5 years;
  • - Suffering from recurrent RTIs.
  • For age-specific definitions of recurrent RTIs, we took cut-offs as defined by the Dutch Society of Pediatrics, i.e. yearly at least 11 and 8 parental-reported upper RTIs including, but not limited to, otitis media for children aged <2 and 2-5 years respectively. Recurrent lower RTIs (i.e. pneumonia, bronchopneumonia or acute bronchitis) are defined as at least 2 episodes per year or 3 or more episodes during the child’s life regardless of age.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 158
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • - Current prophylactic antibiotic use or prophylactic antibiotic use during the previous month;
  • - Underlying immune deficiency other than for IgA or IgG subclasses;
  • - Congenital abnormalities (including cleft palate, neuromuscular, cardial and syndromal disorders, hematologic disorders;
  • - Children who only suffer from recurrent acute otitis media or chronic suppurative otitis media will be excluded since antibiotic prophylaxis has proven to be beneficial for this group;
  • - Known allergy to co-trimoxazole;
  • - Known contra-indication for co-trimoxazole, e.g. liver failure, impaired kidney function and/or hematologic disorders.

研究者

发起方
Haga Teaching Hospital (Juliana Children's Hospital)

相似试验